BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27:595-600. [PMID: 22065114 DOI: 10.1007/s00384-011-1350-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim RH, Mehrazarin S, Kang MK. Therapeutic potential of mesenchymal stem cells for oral and systemic diseases. Dent Clin North Am 2012;56:651-75. [PMID: 22835544 DOI: 10.1016/j.cden.2012.05.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
2 Herreros MD, Garcia-Olmo D, Guadalajara H, Georgiev-Hristov T, Brandariz L, Garcia-Arranz M. Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula. Stem Cells Int. 2019;2019:6132340. [PMID: 31191678 DOI: 10.1155/2019/6132340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
3 Panes J, Reinisch W, Rupniewska E, Khan S, Forns J, Khalid JM, Bojic D, Patel H. Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review. World J Gastroenterol 2018; 24(42): 4821-4834 [PMID: 30479468 DOI: 10.3748/wjg.v24.i42.4821] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
4 Dozois EJ, Lightner AL, Mathis KL, Chua HK, Kelley SR, Fletcher JG, Dietz AB, Friton JJ, Butler GW, Faubion WA. Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular Fistulas. Diseases of the Colon & Rectum 2019;62:615-22. [DOI: 10.1097/dcr.0000000000001333] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
5 Scoglio D, Walker AS, Fichera A. Biomaterials in the treatment of anal fistula: hope or hype? Clin Colon Rectal Surg 2014;27:172-81. [PMID: 25435826 DOI: 10.1055/s-0034-1394156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Lightner AL, Faubion WA. Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: What We Have Accomplished and What We Still Need to Do. Journal of Crohn's and Colitis 2017;11:1267-76. [DOI: 10.1093/ecco-jcc/jjx046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Bloemendaal AL, Buchs NC, George BD, Guy RJ. Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery 2016;159:1237-48. [PMID: 26936524 DOI: 10.1016/j.surg.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ferrer L, Kimbrel EA, Lam A, Falk EB, Zewe C, Juopperi T, Lanza R, Hoffman A. Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn's disease. Regenerative Medicine 2016;11:33-43. [DOI: 10.2217/rme.15.69] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
9 Trébol J, Georgiev-Hristov T, Pascual-Miguelañez I, Guadalajara H, García-Arranz M, García-Olmo D. Stem cell therapy applied for digestive anastomosis: Current state and future perspectives. World J Stem Cells 2022; 14(1): 117-141 [DOI: 10.4252/wjsc.v14.i1.117] [Reference Citation Analysis]
10 Lai P, Weng J, Guo L, Chen X, Du X. Novel insights into MSC-EVs therapy for immune diseases. Biomark Res 2019;7:6. [PMID: 30923617 DOI: 10.1186/s40364-019-0156-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
11 Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, Golfieri R, Campieri M, Poggioli G. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection. Inflamm Bowel Dis 2020;26:321-30. [PMID: 31220252 DOI: 10.1093/ibd/izz051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
12 Uno K, Iijima K, Koike T, Shimosegawa T. Useful strategies to prevent severe stricture after endoscopic submucosal dissection for superficial esophageal neoplasm. World J Gastroenterol 2015; 21(23): 7120-7133 [PMID: 26109798 DOI: 10.3748/wjg.v21.i23.7120] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
13 Beksac K, Tanacan A, Ozgul N, Beksac MS. Treatment of Rectovaginal Fistula Using Sphincteroplasty and Fistulectomy. Obstet Gynecol Int 2018;2018:5298214. [PMID: 29853904 DOI: 10.1155/2018/5298214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ciccocioppo R, Cangemi GC, Kruzliak P, Corazza GR. Concise Review: Cellular Therapies: The Potential to Regenerate and Restore Tolerance in Immune-Mediated Intestinal Diseases. Stem Cells 2016;34:1474-86. [PMID: 27016400 DOI: 10.1002/stem.2367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
15 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Trébol J, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Stem cell therapy for faecal incontinence: Current state and future perspectives. World J Stem Cells 2018; 10(7): 82-105 [PMID: 30079130 DOI: 10.4252/wjsc.v10.i7.82] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
17 Buscail E, Le Cosquer G, Gross F, Lebrin M, Bugarel L, Deraison C, Vergnolle N, Bournet B, Gilletta C, Buscail L. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn's Disease: Rationale, Clinical Results and Perspectives. Int J Mol Sci 2021;22:9967. [PMID: 34576129 DOI: 10.3390/ijms22189967] [Reference Citation Analysis]
18 Hossein-Khannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Hum Cell 2021;34:1289-300. [PMID: 34057700 DOI: 10.1007/s13577-021-00560-w] [Reference Citation Analysis]
19 Riis S, Nielsen FM, Pennisi CP, Zachar V, Fink T. Comparative Analysis of Media and Supplements on Initiation and Expansion of Adipose-Derived Stem Cells. Stem Cells Transl Med 2016;5:314-24. [PMID: 26838270 DOI: 10.5966/sctm.2015-0148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
20 Sémont A, Demarquay C, Bessout R, Durand C, Benderitter M, Mathieu N. Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PLoS One. 2013;8:e70170. [PMID: 23922953 DOI: 10.1371/journal.pone.0070170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
21 Algeri M, Conforti A, Pitisci A, Starc N, Tomao L, Bernardo ME, Locatelli F. Mesenchymal stromal cells and chronic inflammatory bowel disease. Immunol Lett. 2015; Jul 10. [Epub ahead of print]. [PMID: 26170204 DOI: 10.1016/j.imlet.2015.06.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
22 Garcia-Arranz M, Garcia-Olmo D, Herreros MD, Gracia-Solana J, Guadalajara H, de la Portilla F, Baixauli J, Garcia-Garcia J, Ramirez JM, Sanchez-Guijo F, Prosper F;  FISPAC Collaborative Group. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Stem Cells Transl Med. 2020;9:295-301. [PMID: 31886629 DOI: 10.1002/sctm.19-0271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
23 Borowski DW, Gill TS, Agarwal AK, Tabaqchali MA, Garg DK, Bhaskar P. Adipose Tissue-Derived Regenerative Cell-Enhanced Lipofilling for Treatment of Cryptoglandular Fistulae-in-Ano: The ALFA Technique. Surg Innov 2015;22:593-600. [PMID: 25710946 DOI: 10.1177/1553350615572656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
24 Schwartz DA, Ghazi LJ, Regueiro M. Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials. Inflamm Bowel Dis 2015;21:737-52. [PMID: 25751068 DOI: 10.1097/MIB.0000000000000377] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci 2017;62:851-60. [PMID: 28168575 DOI: 10.1007/s10620-017-4453-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
26 Nazari H, Naei VY, Tabasi AH, Badripour A, Akbari Asbagh R, Keramati MR, Sharifi A, Behboudi B, Kazemeini A, Abbasi M, Keshvari A, Ahmadi Tafti SM. Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease. Inflamm Bowel Dis 2021:izab151. [PMID: 34291798 DOI: 10.1093/ibd/izab151] [Reference Citation Analysis]
27 Iwen KA, Priewe AC, Winnefeld M, Rose C, Siemers F, Rohwedel J, Cakiroglu F, Lehnert H, Schepky A, Klein J, Kramer J. Gluteal and abdominal subcutaneous adipose tissue depots as stroma cell source: gluteal cells display increased adipogenic and osteogenic differentiation potentials. Exp Dermatol 2014;23:395-400. [PMID: 24689514 DOI: 10.1111/exd.12406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
28 Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V. Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature. Stem Cells Cloning 2018;11:95-113. [PMID: 30568468 DOI: 10.2147/SCCAA.S135414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Chen Q, Li Y, Wang X, Li H. Hot topics in global perianal fistula research: A scopus-based bibliometric analysis. Medicine (Baltimore) 2020;99:e19659. [PMID: 32332609 DOI: 10.1097/MD.0000000000019659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. Stem Cells Int 2020;2020:7819824. [PMID: 32256612 DOI: 10.1155/2020/7819824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
31 Romano B, Lleo A, Sala E, D’amico G, Marino DI, Ciccocioppo R, Vetrano S. Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions. Curr Transpl Rep 2019;6:134-45. [DOI: 10.1007/s40472-019-00238-1] [Reference Citation Analysis]
32 Ommer A, Herold A, Berg E, Farke S, Fürst A, Hetzer F, Köhler A, Post S, Ruppert R, Sailer M, Schiedeck T, Schwandner O, Strittmatter B, Lenhard BH, Bader W, Krege S, Krammer H, Stange E. S3-Leitlinie: Kryptoglanduläre Analfisteln: 2. revidierte Fassung, AWMF‑Registriernummer: 088/003. coloproctology 2017;39:16-66. [DOI: 10.1007/s00053-016-0110-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
33 Kuhbier JW, Reimers K, Radtke C, Vogt PM. [Regenerative therapy approaches in plastic surgery]. Chirurg 2015;86:214-22. [PMID: 25709000 DOI: 10.1007/s00104-014-2830-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Zhang XM, Zhang YJ, Wang W, Wei YQ, Deng HX. Mesenchymal Stem Cells to Treat Crohn's Disease with Fistula. Hum Gene Ther 2017;28:534-40. [PMID: 28132518 DOI: 10.1089/hum.2016.095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
35 Wang K, Chen X, Ren J. Autologous bone marrow stem cell transplantation in patients with liver failure: a meta-analytic review. Stem Cells Dev 2015;24:147-59. [PMID: 25356526 DOI: 10.1089/scd.2014.0337] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Garcia-Olmo D, Guadalajara H, Rubio-Perez I, Herreros MD, de-la-Quintana P, Garcia-Arranz M. Recurrent anal fistulae: Limited surgery supported by stem cells. World J Gastroenterol 2015; 21(11): 3330-3336 [PMID: 25805941 DOI: 10.3748/wjg.v21.i11.3330] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
37 García-Arranz M, Herreros MD, González-Gómez C, de la Quintana P, Guadalajara H, Georgiev-Hristov T, Trébol J, Garcia-Olmo D. Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial. Stem Cells Transl Med 2016;5:1441-6. [PMID: 27412883 DOI: 10.5966/sctm.2015-0356] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 11.3] [Reference Citation Analysis]
38 Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, Verspaget HW, Fibbe WE, van der Meulen-de Jong AE, Hommes DW. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology. 2015;149:918-27.e6. [PMID: 26116801 DOI: 10.1053/j.gastro.2015.06.014] [Cited by in Crossref: 150] [Cited by in F6Publishing: 141] [Article Influence: 21.4] [Reference Citation Analysis]
39 Boscá MM, Alós R, Maroto N, Gisbert JP, Beltrán B, Chaparro M, Nos P, Mínguez M, Hinojosa J. Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterología y Hepatología (English Edition) 2020;43:155-68. [DOI: 10.1016/j.gastre.2019.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bermejo F, Guerra I, Algaba A, López-Sanromán A. Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease. Drugs 2018;78:1-18. [PMID: 29139091 DOI: 10.1007/s40265-017-0842-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Panés J, Rimola J. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol 2017;14:652-64. [PMID: 28790453 DOI: 10.1038/nrgastro.2017.104] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 15.4] [Reference Citation Analysis]
42 Pariente B, Hu S, Bettenworth D, Speca S, Desreumaux P, Meuwis M, Danese S, Rieder F, Louis E. Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review. Clinical Gastroenterology and Hepatology 2019;17:847-56. [DOI: 10.1016/j.cgh.2018.06.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
43 Gilmore B, Jackson KL, Migaly J. New innovations in anal fistula surgery. Seminars in Colon and Rectal Surgery 2019;30:100707. [DOI: 10.1016/j.scrs.2019.100707] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Wang X, Shen B. Advances in Perianal Disease Associated with Crohn's Disease-Evolving Approaches. Gastrointest Endosc Clin N Am. 2019;29:515-530. [PMID: 31078250 DOI: 10.1016/j.giec.2019.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Pellino G, Keller DS, Sampietro GM, Angriman I, Carvello M, Celentano V, Colombo F, Di Candido F, Laureti S, Luglio G, Poggioli G, Rottoli M, Scaringi S, Sciaudone G, Sica G, Sofo L, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F; Italian Society of Colorectal Surgery SICCR. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease. Tech Coloproctol 2020;24:421-48. [PMID: 32172396 DOI: 10.1007/s10151-020-02183-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
46 Klinger A, Kawata M, Villalobos M, Jones RB, Pike S, Wu N, Chang S, Zhang P, DiMuzio P, Vernengo J, Benvenuto P, Goldfarb RD, Hunter K, Liu Y, Carpenter JP, Tulenko TN. Living scaffolds: surgical repair using scaffolds seeded with human adipose-derived stem cells. Hernia. 2016;20:161-170. [PMID: 26545361 DOI: 10.1007/s10029-015-1415-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
47 Ocansey DKW, Wang L, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med 2019;8:31. [PMID: 31872304 DOI: 10.1186/s40169-019-0251-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
48 Lightner AL, Wang Z, Zubair AC, Dozois EJ. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: Progress Made and Future Directions. Diseases of the Colon & Rectum 2018;61:629-40. [DOI: 10.1097/dcr.0000000000001093] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
49 Hawkey CJ, Hommes DW. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases? Gastroenterology 2017;152:389-397.e2. [PMID: 27845055 DOI: 10.1053/j.gastro.2016.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
50 Maciel Gutiérrez VM, Gutiérrez Guillen SG, Centeno Flores MW, Valenzuela Pérez JA, Abarca Rendón FM, Hernández García FS, De la Cerda Trujillo LF, Gómez Torres GÁ. Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial. Dis Colon Rectum 2021;64:328-34. [PMID: 33538521 DOI: 10.1097/DCR.0000000000001863] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Choi S, Jeon BG, Chae G, Lee SJ. The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol 2019;23:411-27. [PMID: 31049792 DOI: 10.1007/s10151-019-01994-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
52 Benlice C, Yildiz M, Baghaki S, Erguner I, Olgun DC, Batur S, Erdamar S, Ambarcioglu P, Hamzaoglu I, Karahasanoglu T, Baca B. Fistula tract curettage and the use of biological dermal plugs improve high transsphincteric fistula healing in an animal model. Int J Colorectal Dis 2016;31:291-9. [PMID: 26310797 DOI: 10.1007/s00384-015-2374-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
53 Dothel G, Raschi E, Rimondini R, De Ponti F. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology. World J Gastroenterol 2016; 22(41): 9057-9068 [PMID: 27895395 DOI: 10.3748/wjg.v22.i41.9057] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
54 Wainstein C, Quera R, Fluxá D, Kronberg U, Conejero A, López-Köstner F, Jofre C, Zarate AJ. Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up. Colorectal Dis 2018. [PMID: 29316139 DOI: 10.1111/codi.14002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
55 Moussa L, Usunier B, Demarquay C, Benderitter M, Tamarat R, Sémont A, Mathieu N. Bowel Radiation Injury: Complexity of the Pathophysiology and Promises of Cell and Tissue Engineering. Cell Transplant 2016;25:1723-46. [PMID: 27197023 DOI: 10.3727/096368916X691664] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
56 Cassinotti A, Passamonti F, Segato S. CELL THERAPY IN INFLAMMATORY BOWEL DISEASE. Pharmacol Res 2021;163:105247. [PMID: 33069755 DOI: 10.1016/j.phrs.2020.105247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 La Torre M, Lisi G, D’agostino E, Boccuzzi M, Campanelli M, Varriale M, Tierno SM. Lift and VAAFT for high trans-sphincteric anal fistula: a single center retrospective analysis. Int J Colorectal Dis 2020;35:1149-53. [DOI: 10.1007/s00384-020-03584-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Boltin D, Kamenetsky Z, Perets TT, Snir Y, Sapoznikov B, Schmilovitz-weiss H, Ablin JN, Dickman R, Niv Y. Circulating Bone Marrow-Derived CD45−/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn’s Disease. Dig Dis Sci 2017;62:633-8. [DOI: 10.1007/s10620-016-4234-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
59 Li P, Guo X. A review: therapeutic potential of adipose-derived stem cells in cutaneous wound healing and regeneration. Stem Cell Res Ther 2018;9:302. [PMID: 30409218 DOI: 10.1186/s13287-018-1044-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
60 Ibraheim H, Giacomini C, Kassam Z, Dazzi F, Powell N. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease. Expert Rev Gastroenterol Hepatol 2018;12:141-53. [PMID: 29096549 DOI: 10.1080/17474124.2018.1393332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
61 Sun XL, Wen K, Chen YH, Xu ZZ, Wang XP. Long-term outcomes and quality of life following ligation of the intersphincteric fistula tract for high transsphincteric fistulas. Colorectal Dis. 2019;21:30-37. [PMID: 30184334 DOI: 10.1111/codi.14405] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
62 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014;20:1211-27. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
63 Kim N, Cho SG. New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells. 2015;8:54-68. [PMID: 26019755 DOI: 10.15283/ijsc.2015.8.1.54] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 12.0] [Reference Citation Analysis]
64 Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3:249-260. [PMID: 31276044 DOI: 10.1002/jgh3.12141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
65 Spotnitz WD. Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective. ISRN Surg 2014;2014:203943. [PMID: 24729902 DOI: 10.1155/2014/203943] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 16.4] [Reference Citation Analysis]
66 Watanabe S, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nasuno M, Yamashita K, Idogawa M, Naishiro Y, Murata M, Adachi Y, Fujimiya M, Imai K, Shinomura Y. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors. J Gastroenterol. 2014;49:270-282. [PMID: 24217964 DOI: 10.1007/s00535-013-0901-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
67 Sebbagh AC, Rosenbaum B, Péré G, Alric H, Berger A, Wilhelm C, Gazeau F, Mathieu N, Rahmi G, Silva AKA. Regenerative medicine for digestive fistulae therapy: Benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021;:113841. [PMID: 34175308 DOI: 10.1016/j.addr.2021.113841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Bor R, Fábián A, Farkas K, Molnár T, Szepes Z. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data. Expert Opinion on Biological Therapy 2018;18:737-45. [DOI: 10.1080/14712598.2018.1492543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, Sørensen JA. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Transl Med 2017;6:1786-94. [PMID: 28722289 DOI: 10.1002/sctm.17-0031] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 14.2] [Reference Citation Analysis]
70 Nam YS, Kim N, Im KI, Lim JY, Lee ES, Cho SG. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World J Gastroenterol 2015; 21(7): 2030-2039 [PMID: 25717235 DOI: 10.3748/wjg.v21.i7.2030] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
71 Giordano P, Sileri P, Buntzen S, Nunoo-Mensah J, Lenisa L, Singh B, Thorlacius-Ussing O, Griffiths B, Vujovic Z, Stuto A. Final results of a European, multicentre, prospective, observational study of Permacol™ collagen paste injection for the treatment of anal fistula. Colorectal Dis 2018;20:243-51. [PMID: 28493393 DOI: 10.1111/codi.13715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
72 Kobayashi S, Kanai N, Ohki T, Takagi R, Yamaguchi N, Isomoto H, Kasai Y, Hosoi T, Nakao K, Eguchi S, Yamamoto M, Yamato M, Okano T. Prevention of esophageal strictures after endoscopic submucosal dissection. World J Gastroenterol 2014; 20(41): 15098-15109 [PMID: 25386058 DOI: 10.3748/wjg.v20.i41.15098] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
73 Zuk P. Adipose-Derived Stem Cells in Tissue Regeneration: A Review. ISRN Stem Cells 2013;2013:1-35. [DOI: 10.1155/2013/713959] [Cited by in Crossref: 83] [Cited by in F6Publishing: 24] [Article Influence: 9.2] [Reference Citation Analysis]
74 Guillo L, Grimaud F, Houser F, Prost C, Jouve E, Philandrianos C, Abellan M, Veran J, Visee C, Beyer-Berjot L, Desjeux A, Dignat-George F, Leone M, Grimaud JC, Sabatier F, Serrero M, Magalon J. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease. Stem Cell Res Ther 2022;13:67. [PMID: 35139888 DOI: 10.1186/s13287-022-02738-x] [Reference Citation Analysis]
75 Limura E, Giordano P. Modern management of anal fistula. World J Gastroenterol 2015; 21(1): 12-20 [PMID: 25574077 DOI: 10.3748/wjg.v21.i1.12] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 54] [Article Influence: 12.4] [Reference Citation Analysis]
76 Cho YB, Park KJ, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Jeong HY, Yu CS. Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula. Stem Cells Transl Med. 2015;4:532-537. [PMID: 25829404 DOI: 10.5966/sctm.2014-0199] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 14.4] [Reference Citation Analysis]
77 Lim MH, Ong WK, Sugii S. The current landscape of adipose-derived stem cells in clinical applications. Expert Rev Mol Med 2014;16. [DOI: 10.1017/erm.2014.8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
78 Andjelkov K, Sforza M, Barisic G, Soldatovic I, Hiranyakas A, Krivokapic Z. A novel method for treatment of chronic anal fissure: adipose-derived regenerative cells - a pilot study. Colorectal Dis 2017;19:570-5. [DOI: 10.1111/codi.13555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
79 Lewis R, Lunniss PJ, Hammond TM. Novel biological strategies in the management of anal fistula. Colorectal Dis. 2012;14:1445-1455. [PMID: 22882376 DOI: 10.1111/j.1463-1318.2012.03192.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
80 Baik SH, Kim WH. A comprehensive review of inflammatory bowel disease focusing on surgical management. J Korean Soc Coloproctol 2012;28:121-31. [PMID: 22816055 DOI: 10.3393/jksc.2012.28.3.121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Castro-poceiro J, Fernández-clotet A, Panés J. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease. Immunotherapy 2018;10:1203-17. [DOI: 10.2217/imt-2018-0099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Cheng F, Huang Z, Li Z. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis. Tech Coloproctol. 2019;23:613-623. [PMID: 31286287 DOI: 10.1007/s10151-019-02024-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
83 Fagoonee S, Famulari ES, Silengo L, Camussi G, Altruda F. Prospects for Adult Stem Cells in the Treatment of Liver Diseases. Stem Cells Dev. 2016; Epub ahead of print. [PMID: 27503633 DOI: 10.1089/scd.2016.0144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
84 Grégoire C, Lechanteur C, Briquet A, Baudoux É, Baron F, Louis E, Beguin Y. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther 2017;45:205-21. [PMID: 27878827 DOI: 10.1111/apt.13864] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
85 Strobel S, Abreu MT. Update on idiopathic colitides. Curr Opin Gastroenterol 2013;29:60-5. [PMID: 23207597 DOI: 10.1097/MOG.0b013e32835abc93] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Fierabracci A, Del Fattore A, Luciano R, Muraca M, Teti A, Muraca M. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles. Cell Transplant. 2015;24:133-149. [PMID: 24268069 DOI: 10.3727/096368913x675728] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
87 Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC, Scharl M. Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:995-1009. [PMID: 32160284 DOI: 10.1093/ecco-jcc/jjaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
88 Ryska O, Serclova Z, Mestak O, Matouskova E, Vesely P, Mrazova I. Local application of adipose-derived mesenchymal stem cells supports the healing of fistula: prospective randomised study on rat model of fistulising Crohn’s disease. Scandinavian Journal of Gastroenterology 2017;52:543-50. [DOI: 10.1080/00365521.2017.1281434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
89 Nagaishi K, Arimura Y, Fujimiya M. Stem cell therapy for inflammatory bowel disease. J Gastroenterol. 2015;50:280-286. [PMID: 25618180 DOI: 10.1007/s00535-015-1040-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
90 Pan H, Lam PK, Tong SW, Leung KK, Teoh AY, Ng EK. Mesenchymal Stem Cells Combined with Tissue Fusion Technology Promoted Wound Healing in Porcine Bowel Anastomosis. Stem Cells Int 2020;2020:5142797. [PMID: 32104185 DOI: 10.1155/2020/5142797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Giordano P, Sileri P, Buntzen S, Stuto A, Nunoo-mensah J, Lenisa L, Singh B, Thorlacius-ussing O, Griffiths B, Ziyaie D. A prospective multicentre observational study of Permacol collagen paste for anorectal fistula: preliminary results. Colorectal Dis 2016;18:286-94. [DOI: 10.1111/codi.13112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
92 Tozer P, Borowski DW, Gupta A, Yassin N, Phillips R, Hart A. Managing perianal Crohn's fistula in the anti-TNFα era. Tech Coloproctol 2015;19:673-8. [PMID: 26264168 DOI: 10.1007/s10151-015-1332-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
93 Sheedy SP, Bruining DH, Dozois EJ, Faubion WA, Fletcher JG. MR Imaging of Perianal Crohn Disease. Radiology. 2017;282:628-645. [PMID: 28218881 DOI: 10.1148/radiol.2016151491] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 10.2] [Reference Citation Analysis]
94 Ciccocioppo R, Gallia A, Sgarella A, Kruzliak P, Gobbi PG, Corazza GR. Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells. Mayo Clin Proc. 2015;90:747-755. [PMID: 26046409 DOI: 10.1016/j.mayocp.2015.03.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 9.1] [Reference Citation Analysis]
95 van Deen WK, Oikonomopoulos A, Hommes DW. Stem cell therapy in inflammatory bowel disease: which, when and how? Curr Opin Gastroenterol. 2013;29:384-390. [PMID: 23666365 DOI: 10.1097/mog.0b013e328361f763] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
96 Garcia-Olmo D, Schwartz DA. Cumulative Evidence That Mesenchymal Stem Cells Promote Healing of Perianal Fistulas of Patients With Crohn’s Disease--Going From Bench to Bedside. Gastroenterology. 2015;149:853-857. [PMID: 26311275 DOI: 10.1053/j.gastro.2015.08.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
97 Wang G, Qiu L, Li X, Pan Y, Sheng Y, Neumann K, Sun Y, Wang Y, Liu L, Deng L, Bradley M, Zhang R. Novel copolymers drive differentiation of human adipose derived stem cells towards chondrocytes and osteoblasts identified by high-throughput approach. Biomed Phys Eng Express 2020;6:025005. [PMID: 33438631 DOI: 10.1088/2057-1976/ab7155] [Reference Citation Analysis]
98 Moussa L, Demarquay C, Réthoré G, Benadjaoud MA, Siñeriz F, Pattapa G, Guicheux J, Weiss P, Barritault D, Mathieu N. Heparan Sulfate Mimetics: A New Way to Optimize Therapeutic Effects of Hydrogel-Embedded Mesenchymal Stromal Cells in Colonic Radiation-Induced Damage. Sci Rep 2019;9:164. [PMID: 30655576 DOI: 10.1038/s41598-018-36631-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Cheng F, Huang Z, Li Z. Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis. Stem Cells Int 2020;2020:8816737. [PMID: 33299423 DOI: 10.1155/2020/8816737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Yoo H, Kim I, Ha H, Yu CS. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula: ASCs for the Treatment of Crohn's Fistula. Stem Cells 2013;31:2575-81. [DOI: 10.1002/stem.1357] [Cited by in Crossref: 165] [Cited by in F6Publishing: 151] [Article Influence: 18.3] [Reference Citation Analysis]
101 He Y, Lu F. Development of Synthetic and Natural Materials for Tissue Engineering Applications Using Adipose Stem Cells. Stem Cells Int. 2016;2016:5786257. [PMID: 26977158 DOI: 10.1155/2016/5786257] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
102 Boscá MM, Alós R, Maroto N, Gisbert JP, Beltrán B, Chaparro M, Nos P, Mínguez M, Hinojosa J. Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease. Gastroenterol Hepatol 2020;43:155-68. [PMID: 31870681 DOI: 10.1016/j.gastrohep.2019.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Borowski DW, Gill TS, Agarwal AK, Bhaskar P. Autologous adipose-tissue derived regenerative cells for the treatment of complex cryptoglandular fistula-in-ano: a report of three cases. BMJ Case Rep 2012;2012:bcr2012006988. [PMID: 23144344 DOI: 10.1136/bcr-2012-006988] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
104 Almeida-Porada G, Soland M, Boura J, Porada CD. Regenerative medicine: prospects for the treatment of inflammatory bowel disease. Regen Med. 2013;8:631-644. [PMID: 23998755 DOI: 10.2217/rme.13.52] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
105 Gecse KB, Bemelman W, Kamm MA, Stoker J, Khanna R, Ng SC, Panés J, van Assche G, Liu Z, Hart A. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63:1381-1392. [PMID: 24951257 DOI: 10.1136/gutjnl-2013-306709] [Cited by in Crossref: 210] [Cited by in F6Publishing: 172] [Article Influence: 26.3] [Reference Citation Analysis]
106 Rakinic J, Poola VP. Hemorrhoids and fistulas: new solutions to old problems. Curr Probl Surg 2014;51:98-137. [PMID: 24606821 DOI: 10.1067/j.cpsurg.2013.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
107 El-Nakeep S, Shawky A, Abbas SF, Abdel Latif O. Stem cell transplantation for induction of remission in medically refractory Crohn's disease. Cochrane Database Syst Rev 2022;5:CD013070. [PMID: 35556242 DOI: 10.1002/14651858.CD013070.pub2] [Reference Citation Analysis]
108 Hassanshahi A, Hassanshahi M, Khabbazi S, Hosseini‐khah Z, Peymanfar Y, Ghalamkari S, Su Y, Xian CJ. Adipose‐derived stem cells for wound healing. J Cell Physiol 2019;234:7903-14. [DOI: 10.1002/jcp.27922] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
109 Moniuszko A, Sarnowska A, Rogowski W, Durlik M, Wluka A, Rydzewska G. Successful treatment of an enterovesical fistula due to Crohn's disease with stem cell transplantation: a case report. Prz Gastroenterol 2018;13:332-6. [PMID: 30581508 DOI: 10.5114/pg.2018.79814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]